Compare DNTH & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNTH | ASB |
|---|---|---|
| Founded | 2015 | 1861 |
| Country | United States | United States |
| Employees | 92 | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.2B |
| IPO Year | 2018 | N/A |
| Metric | DNTH | ASB |
|---|---|---|
| Price | $82.21 | $29.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $121.00 | $29.75 |
| AVG Volume (30 Days) | 909.4K | ★ 1.7M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | N/A | $21.24 |
| Revenue Next Year | $29.48 | $8.86 |
| P/E Ratio | ★ N/A | $10.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.77 | $22.88 |
| 52 Week High | $96.50 | $29.96 |
| Indicator | DNTH | ASB |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 59.07 |
| Support Level | $79.27 | $27.03 |
| Resistance Level | $92.41 | $29.52 |
| Average True Range (ATR) | 5.51 | 0.58 |
| MACD | -0.21 | 0.12 |
| Stochastic Oscillator | 54.28 | 72.59 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.